News Press Release

"Canon Medical Systems Corporation, working together with Nagasaki University, has completed development of Genelyzer KIT, a set of reagents for SARS-CoV-2 RNA testing based on a gene amplification technique known as the fluorescent LAMP method."

"Canon Medical Systems Corporation has begun research into the practical application of a new rapid genetic testing system for the novel coronavirus (SARS-CoV-2) which is being developed by Canon Medical Systems Corporation in cooperation with Nagasaki University."

"Ohtawara, Japan; February 26 Canon Medical Systems Corporation (Canon Medical) announces the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19) reaffirming the company’s commitment to the basic research and development of rapid diagnostic test kits."

"Canon (China) Co., Ltd., Canon Medical Systems (China) Co., Ltd. and all members of the Canon Group, via the National Health Commission of the People’s Republic of China, will donate a full-body X-ray CT diagnosis system to the Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, in the city of Wuhan."

"As part of Canon Inc.’s global medical business strategic realignment, the eye care business operations within Canon U.S.A., Inc. will transfer to Canon Medical Systems USA, Inc. effective January 1, 2020."

"Canon Medical Systems Corporation has concluded a contract to acquire all shares of Skope Magnetic Resonance Technologies AG."

"Canon Medical Systems Corporation is pleased to announce the official opening of its Middle East Division in Canon Middle East Dubai, UAE. Preparations are now underway to start business operations around the beginning of January 2020."

"Canon Medical Systems Corporation (Canon Medical) announces completion of an agreement with US-based FemtoDx, Inc. (FemtoDx) relating to a capital investment based on stock purchase."

"Canon Inc. (Headquarters: Ohta-ku, Tokyo, Japan; Chairman and CEO: Fujio Mitarai) Canon Medical Systems Corporation (“Canon Medical”; Headquarters: Tochigi Prefecture, Japan; President: Toshio Takiguchi) and the Center for iPS Cell Research and Application, Kyoto University (“CiRA”; Headquarters: Sakyo-ku, Kyoto, Japan; Director: Shinya Yamanaka) announced today that the parties have agreed to commence joint research from August 1, 2019, with the aim of contributing to the field of regenerative medicine through the realization of higher-quality induced pluripotent stem (iPS) cells1 for autograft purposes, or “my iPS cells2.”"

Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio Takiguchi) has agreed to establish a framework with R-Pharm Holding (a part of R-Pharm Group, headquarters: Moscow, Russia; Chairman and President: Alexey Repik), a leader of Russian healthcare market, to promote sales of diagnostic imaging systems manufactured by Canon Medical Systems, and to localize Canon’s medical equipment production at R-Pharm’s facilities in Russia.

"Otawara, Japan; May 16, 2019- Canon Medical Systems Corporation (Canon Medical) will present Deep Learning Reconstruction (DLR) technology at the International Society for Magnetic Resonance in Medicine (ISMRM) 2019 Annual meeting in Montreal, Vancouver."

"January 28, 2019; Otawara, Japan – Canon Medical Systems Corporation (Canon Medical) introduces Global Illumination rendering technology within the Vitrea® platform. This technology allows physicians to interact in real-time with photorealistic images and visualize patient anatomy in all dimensions."

"Canon Medical Systems Corporation and Ichiban S.A. de Inversión reached an agreement on the conditions for transferring the assets related to the distributor business of GRIENSU S.A. to Canon Medical Systems Argentina S.A. on August 7, 2018 (local time)."

"Canon Medical Systems Corporation has agreed to subscribe to a third-party allotment from LPixel Inc."

"October 20, 2018: Under their new company name Canon Medical will be Diamond sponsor of the ISUOG World Congress and host a four-day program of educational activities, including insight sessions, satellite symposium and live scans. Key opinion leaders in maternal fetal medicine have been invited to share their experiences and demonstrate the clinical value of Canon’s imaging technologies."

"Canon Medical Systems Corporation (Canon Medical) announces the showcasing of a new Ultra-High Resolution research-enabled 3T MRI System, representing the latest addition to its Magnetic Resonance Imaging portfolio, at the ISMRM-ESMRMB 2018 Joint Annual Meeting in Paris, France."

Canon Medical Systems Corporation at the 2018 Ceremony of National Commendation for Invention, hosted by Japan Institute of Invention and Innovation, received the Minister of Education, Culture, Sports, Science and Technology Award and the Invention Achievement Award.

"Canon Medical Systems Corporation today announced an agreement with NVIDIA to co-develop and commercialize deep-learning research infrastructure in Japan for medical research institutions, such as university hospitals."

"Canon Medical Systems Corporation announces today commencement of Japan sales of its next-generation family of interventional system, Alphenix, after receiving approval from the Japan Ministry of Health, Labour and Welfare."